Global Women’s Healthcare Market Forecast 2017-2027

LONDON, August 1, 2017 /PRNewswire/ --

Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome

The revenue of the women's healthcare market in 2016 is estimated at $31.1bn and is expected to grow at a CAGR of 3.8% in the first half of the forecast period. Among various segments in the Women's Healthcare market, the Postmenopausal Osteoporosis segment dominated the Global Women's Healthcare market with a share of 36.99% in 2016.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 96 charts - all unavailable elsewhere.

The 154-page report provides clear detailed insight into the women's healthcare market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope: 

• Global Women's Healthcare market forecasts from 2017-2027

• This report also breaks down the revenue forecast and SWOT Analysis for the main submarkets:
• Postmenopausal Osteoporosis
• Hormonal Contraceptives
• Infertility
• Endometriosis
• Polycystic Ovary Syndrome

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• The US and Latin America
• Japan
• The UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Rest of the World

• This report provides discussion on pipeline products in various stages of clinical trials and regulatory approval.

• This report also discusses the drivers, challenges and trends that affect the global women's healthcare market.

• Our study discusses the selected leading companies that are the major players in the global women's healthcare market.
• Bayer
• Eli Lilly
• Merck & Co.
• Pfizer
• Sanofi
• Amgen
• Novo Nordisk
• AbbVie
• Bristol-Myers Squibb (BMS)

Visiongain's study is intended for anyone requiring commercial analyses for the women's healthcare market. You find data, trends and predictions.

Buy our report today Global Women's Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome.

To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100.

Or click on https://www.visiongain.com/Report/1940/Global-Women%E2%80%99s-Healthcare-Market-Forecast-2017-2027

List of Companies Mentioned in the Report: 

AbbVie

Actavis

Adamis Pharmaceuticals

Agile Therapeutics

Allergan

Amgen

ANI Pharmaceuticals

Apothecus Pharmaceutical

AstraZeneca

Bayer

Bristol-Myers Squibb (BMS)

Catalysis

Ciba-Geigy

Conceptus

Crinetics Pharmaceuticals Inc.

Dexa Medica Group

EffRX

Eli Lilly

EndoCeutics

Ferring International Center

Ferring Pharmaceuticals

GlaxoSmithKline (GSK)

HLL Lifecare

Janssen

Ligand Pharmaceuticals

Lipocine

Lupin Pharmaceuticals

Mayer Laboratories

Medicines 360

Merck & Co.

Merck KGaA

Merus Labs

Mylan Laboratories

Neurocrine Biosciences

Novartis

Novo Nordisk

OPKO Health

Pantarhei Bioscience B.V.

Pfizer

Radius Health

Samsung Bioepsis

Sandoz

Sanofi

Sanofi Pasteur

Sanofi Synthelabo

Sanofi-Aventis

Tarsa Therapeutics

Teva Pharmaceuticals

Warner Chilcott

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain Ltd